MedPath

Effects of Fumaria Parviflora on diabetic patients

Phase 3
Conditions
Type 2 diabetic patients.
Diabetes mellitus due to underlying condition
Registration Number
IRCT20130610013612N11
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
66
Inclusion Criteria

Patients who agree to participate in the study
Women aged 20 to 50 years (non-menopausal) and men 20 to 65 years
BMI range between 25 and 40 kg /m2
; Having type 2 diabetes for at least 6 months while taking blood sugar-lowering drugs (metformin and thiazolidine )

Exclusion Criteria

Reluctance to participate in the study
Insulin injection
Use any nutritional supplements such as omega-3 supplements or supplements that have anti-inflammatory and antioxidant properties in the past 3 months or during the study
Liver and kidney failure and thyroid diseases
Smoking and alcohol consumption
Patients using NSAIDs, corticosteroids (prednisone, prednisolone, and hydrocortisone), thiazide (furosemide and hydrochlorothiazide), and second-generation antipsychotics (olanzapine and clozapine).
Pregnancy and desire to conceive during the study
Intestinal and gastrointestinal diseases and eating disorders

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath